nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP1A2—urine—polycystic ovary syndrome	0.0187	0.0883	CbGeAlD
Ropivacaine—Acidosis—Metformin—polycystic ovary syndrome	0.0185	0.0673	CcSEcCtD
Ropivacaine—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0183	0.0665	CcSEcCtD
Ropivacaine—Hypothermia—Metformin—polycystic ovary syndrome	0.0183	0.0665	CcSEcCtD
Ropivacaine—CYP3A4—urine—polycystic ovary syndrome	0.0135	0.0639	CbGeAlD
Ropivacaine—CYP2D6—urine—polycystic ovary syndrome	0.0133	0.0629	CbGeAlD
Ropivacaine—Rigors—Metformin—polycystic ovary syndrome	0.0126	0.0456	CcSEcCtD
Ropivacaine—SCN9A—pituitary gland—polycystic ovary syndrome	0.011	0.0519	CbGeAlD
Ropivacaine—SCN9A—adipose tissue—polycystic ovary syndrome	0.0109	0.0517	CbGeAlD
Ropivacaine—SCN9A—adrenal gland—polycystic ovary syndrome	0.00979	0.0464	CbGeAlD
Ropivacaine—SCN4A—pituitary gland—polycystic ovary syndrome	0.00978	0.0463	CbGeAlD
Ropivacaine—SCN4A—adipose tissue—polycystic ovary syndrome	0.00974	0.0461	CbGeAlD
Ropivacaine—SCN8A—endocrine gland—polycystic ovary syndrome	0.00967	0.0458	CbGeAlD
Ropivacaine—Neuropathy—Metformin—polycystic ovary syndrome	0.00963	0.035	CcSEcCtD
Ropivacaine—SCN4A—adrenal gland—polycystic ovary syndrome	0.00874	0.0414	CbGeAlD
Ropivacaine—SCN2A—pituitary gland—polycystic ovary syndrome	0.00866	0.041	CbGeAlD
Ropivacaine—SCN10A—pituitary gland—polycystic ovary syndrome	0.00835	0.0395	CbGeAlD
Ropivacaine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00763	0.0277	CcSEcCtD
Ropivacaine—SCN3A—pituitary gland—polycystic ovary syndrome	0.00761	0.036	CbGeAlD
Ropivacaine—SCN3A—adipose tissue—polycystic ovary syndrome	0.00758	0.0359	CbGeAlD
Ropivacaine—SCN2A—vagina—polycystic ovary syndrome	0.00717	0.0339	CbGeAlD
Ropivacaine—SCN3A—adrenal gland—polycystic ovary syndrome	0.0068	0.0322	CbGeAlD
Ropivacaine—Breast disorder—Metformin—polycystic ovary syndrome	0.00673	0.0244	CcSEcCtD
Ropivacaine—SCN2A—endocrine gland—polycystic ovary syndrome	0.00671	0.0318	CbGeAlD
Ropivacaine—Cramp muscle—Metformin—polycystic ovary syndrome	0.00671	0.0244	CcSEcCtD
Ropivacaine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00648	0.0235	CcSEcCtD
Ropivacaine—SCN10A—endocrine gland—polycystic ovary syndrome	0.00647	0.0306	CbGeAlD
Ropivacaine—SCN3A—vagina—polycystic ovary syndrome	0.0063	0.0298	CbGeAlD
Ropivacaine—SCN5A—vagina—polycystic ovary syndrome	0.00628	0.0297	CbGeAlD
Ropivacaine—Sweating increased—Metformin—polycystic ovary syndrome	0.00627	0.0228	CcSEcCtD
Ropivacaine—Drowsiness—Metformin—polycystic ovary syndrome	0.00574	0.0208	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00563	0.0204	CcSEcCtD
Ropivacaine—Bradycardia—Metformin—polycystic ovary syndrome	0.00524	0.019	CcSEcCtD
Ropivacaine—Rhinitis—Metformin—polycystic ovary syndrome	0.00516	0.0188	CcSEcCtD
Ropivacaine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00513	0.0186	CcSEcCtD
Ropivacaine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00508	0.0184	CcSEcCtD
Ropivacaine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00478	0.0174	CcSEcCtD
Ropivacaine—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00474	0.0224	CbGeAlD
Ropivacaine—Chills—Metformin—polycystic ovary syndrome	0.00462	0.0168	CcSEcCtD
Ropivacaine—Erythema—Metformin—polycystic ovary syndrome	0.00448	0.0163	CcSEcCtD
Ropivacaine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00431	0.0157	CcSEcCtD
Ropivacaine—Vision blurred—Metformin—polycystic ovary syndrome	0.00423	0.0153	CcSEcCtD
Ropivacaine—Tremor—Metformin—polycystic ovary syndrome	0.0042	0.0153	CcSEcCtD
Ropivacaine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00416	0.0151	CcSEcCtD
Ropivacaine—Malaise—Metformin—polycystic ovary syndrome	0.00404	0.0147	CcSEcCtD
Ropivacaine—Syncope—Metformin—polycystic ovary syndrome	0.00402	0.0146	CcSEcCtD
Ropivacaine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00394	0.0143	CcSEcCtD
Ropivacaine—Hypertension—Metformin—polycystic ovary syndrome	0.00387	0.0141	CcSEcCtD
Ropivacaine—Chest pain—Metformin—polycystic ovary syndrome	0.00382	0.0139	CcSEcCtD
Ropivacaine—Myalgia—Metformin—polycystic ovary syndrome	0.00382	0.0139	CcSEcCtD
Ropivacaine—Discomfort—Metformin—polycystic ovary syndrome	0.00377	0.0137	CcSEcCtD
Ropivacaine—Infection—Metformin—polycystic ovary syndrome	0.00364	0.0132	CcSEcCtD
Ropivacaine—Shock—Metformin—polycystic ovary syndrome	0.0036	0.0131	CcSEcCtD
Ropivacaine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00358	0.013	CcSEcCtD
Ropivacaine—Skin disorder—Metformin—polycystic ovary syndrome	0.00356	0.0129	CcSEcCtD
Ropivacaine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00354	0.0128	CcSEcCtD
Ropivacaine—Hypotension—Metformin—polycystic ovary syndrome	0.00342	0.0124	CcSEcCtD
Ropivacaine—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00342	0.0162	CbGeAlD
Ropivacaine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00333	0.0121	CcSEcCtD
Ropivacaine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00329	0.0119	CcSEcCtD
Ropivacaine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00326	0.0118	CcSEcCtD
Ropivacaine—Somnolence—Metformin—polycystic ovary syndrome	0.00325	0.0118	CcSEcCtD
Ropivacaine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00322	0.0117	CcSEcCtD
Ropivacaine—CYP2B6—vagina—polycystic ovary syndrome	0.00317	0.015	CbGeAlD
Ropivacaine—Constipation—Metformin—polycystic ovary syndrome	0.00313	0.0114	CcSEcCtD
Ropivacaine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00309	0.0147	CbGeAlD
Ropivacaine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00302	0.011	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00299	0.0109	CcSEcCtD
Ropivacaine—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00297	0.014	CbGeAlD
Ropivacaine—Urticaria—Metformin—polycystic ovary syndrome	0.00291	0.0106	CcSEcCtD
Ropivacaine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00289	0.0105	CcSEcCtD
Ropivacaine—Asthenia—Metformin—polycystic ovary syndrome	0.00263	0.00954	CcSEcCtD
Ropivacaine—Pruritus—Metformin—polycystic ovary syndrome	0.00259	0.0094	CcSEcCtD
Ropivacaine—Diarrhoea—Metformin—polycystic ovary syndrome	0.0025	0.00909	CcSEcCtD
Ropivacaine—Dizziness—Metformin—polycystic ovary syndrome	0.00242	0.00879	CcSEcCtD
Ropivacaine—CYP2D6—female gonad—polycystic ovary syndrome	0.00237	0.0112	CbGeAlD
Ropivacaine—Vomiting—Metformin—polycystic ovary syndrome	0.00233	0.00845	CcSEcCtD
Ropivacaine—Rash—Metformin—polycystic ovary syndrome	0.00231	0.00838	CcSEcCtD
Ropivacaine—Dermatitis—Metformin—polycystic ovary syndrome	0.00231	0.00837	CcSEcCtD
Ropivacaine—Headache—Metformin—polycystic ovary syndrome	0.00229	0.00833	CcSEcCtD
Ropivacaine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00224	0.0106	CbGeAlD
Ropivacaine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.0022	0.0104	CbGeAlD
Ropivacaine—Nausea—Metformin—polycystic ovary syndrome	0.00217	0.00789	CcSEcCtD
Ropivacaine—SCN10A—Developmental Biology—LEP—polycystic ovary syndrome	0.000465	0.000906	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00046	0.000897	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000457	0.000891	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000454	0.000884	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—INS—polycystic ovary syndrome	0.000449	0.000874	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000444	0.000865	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00044	0.000857	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000437	0.000852	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000435	0.000848	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000434	0.000846	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000434	0.000844	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—INS—polycystic ovary syndrome	0.000429	0.000836	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000429	0.000835	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000428	0.000833	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000422	0.000822	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00042	0.000819	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00042	0.000819	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000418	0.000814	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000417	0.000812	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000415	0.000808	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000414	0.000807	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—INS—polycystic ovary syndrome	0.000412	0.000803	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—INS—polycystic ovary syndrome	0.000412	0.000803	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000409	0.000797	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000405	0.000789	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000405	0.000789	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.0004	0.00078	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000398	0.000776	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000398	0.000776	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000398	0.000774	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—INS—polycystic ovary syndrome	0.000398	0.000774	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—INS—polycystic ovary syndrome	0.000398	0.000774	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000397	0.000774	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000393	0.000765	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00039	0.00076	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000387	0.000754	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000385	0.000749	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000384	0.000748	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000384	0.000748	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000383	0.000746	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00038	0.00074	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000365	0.000711	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000365	0.000711	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000364	0.000709	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000363	0.000707	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000363	0.000706	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000358	0.000696	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000352	0.000685	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000352	0.000685	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00035	0.000683	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000345	0.000673	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00034	0.000662	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—IL6—polycystic ovary syndrome	0.00034	0.000662	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000339	0.00066	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000336	0.000654	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000335	0.000653	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000334	0.000651	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00033	0.000643	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00033	0.000643	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	0.000327	0.000637	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000325	0.000632	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000316	0.000615	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SUOX—polycystic ovary syndrome	0.000316	0.000615	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000311	0.000606	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000309	0.000602	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000307	0.000598	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000301	0.000586	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000297	0.000578	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000294	0.000572	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—POMC—polycystic ovary syndrome	0.000293	0.00057	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000287	0.000559	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000285	0.000555	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000283	0.000552	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000283	0.000551	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00028	0.000546	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00028	0.000545	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	0.000279	0.000544	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000277	0.000539	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000276	0.000537	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6—polycystic ovary syndrome	0.000275	0.000535	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000273	0.000532	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000271	0.000528	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00027	0.000526	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000269	0.000524	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6—polycystic ovary syndrome	0.000263	0.000512	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000262	0.000511	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00026	0.000507	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00026	0.000507	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—polycystic ovary syndrome	0.000252	0.000492	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—polycystic ovary syndrome	0.000252	0.000492	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000251	0.000489	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000251	0.000489	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000251	0.000488	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00025	0.000487	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TEAD2—polycystic ovary syndrome	0.00025	0.000486	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKR1C2—polycystic ovary syndrome	0.00025	0.000486	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000247	0.000482	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	0.000243	0.000474	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—polycystic ovary syndrome	0.000243	0.000474	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—polycystic ovary syndrome	0.000242	0.000472	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.00024	0.000468	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000231	0.00045	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000228	0.000444	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000221	0.000431	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.00022	0.000428	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.00022	0.000428	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000218	0.000425	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000213	0.000414	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000209	0.000408	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000204	0.000398	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000204	0.000396	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000203	0.000396	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000198	0.000386	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—polycystic ovary syndrome	0.000196	0.000382	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000194	0.000378	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00019	0.000369	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—STAR—polycystic ovary syndrome	0.000189	0.000369	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—polycystic ovary syndrome	0.000187	0.000365	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000186	0.000362	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000186	0.000362	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000184	0.000358	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—polycystic ovary syndrome	0.00018	0.000351	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—polycystic ovary syndrome	0.00018	0.000351	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000178	0.000348	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000177	0.000344	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000176	0.000343	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	0.000174	0.000338	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—polycystic ovary syndrome	0.000174	0.000338	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000174	0.000338	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000174	0.000338	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000173	0.000337	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000172	0.000336	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.000171	0.000333	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000169	0.000329	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	0.000169	0.000329	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000161	0.000313	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000158	0.000307	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000157	0.000306	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00015	0.000292	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000147	0.000286	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000147	0.000286	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	0.000147	0.000286	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000145	0.000283	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000144	0.00028	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000144	0.00028	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000143	0.000279	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000141	0.000275	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000139	0.000271	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000139	0.000271	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000138	0.000269	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000133	0.00026	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000133	0.000259	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000132	0.000256	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000128	0.000249	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	0.000124	0.000241	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000123	0.00024	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	0.000122	0.000238	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	0.000119	0.000232	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000117	0.000228	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000117	0.000228	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	0.000115	0.000223	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000114	0.000221	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000114	0.000221	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000113	0.000221	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000112	0.000218	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000111	0.000217	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00011	0.000215	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000107	0.000208	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000105	0.000205	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000102	0.000199	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	9.97e-05	0.000194	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	9.93e-05	0.000193	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	9.66e-05	0.000188	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.51e-05	0.000185	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	9.48e-05	0.000185	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.37e-05	0.000182	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TH—polycystic ovary syndrome	9.11e-05	0.000177	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.02e-05	0.000176	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	8.89e-05	0.000173	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.88e-05	0.000173	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	8.86e-05	0.000173	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	8.64e-05	0.000168	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	8.61e-05	0.000168	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.6e-05	0.000168	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	8.45e-05	0.000165	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	8.33e-05	0.000162	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	8.3e-05	0.000162	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	8.18e-05	0.000159	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	7.97e-05	0.000155	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	7.87e-05	0.000153	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.67e-05	0.000149	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	7.53e-05	0.000147	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	7.44e-05	0.000145	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	7.43e-05	0.000145	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	7.32e-05	0.000143	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.31e-05	0.000142	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	7.29e-05	0.000142	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	7.09e-05	0.000138	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	7.03e-05	0.000137	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	6.75e-05	0.000132	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	6.72e-05	0.000131	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.71e-05	0.000131	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.67e-05	0.00013	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	6.67e-05	0.00013	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.62e-05	0.000129	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.52e-05	0.000127	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	6.33e-05	0.000123	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.31e-05	0.000123	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	6.3e-05	0.000123	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	6.26e-05	0.000122	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	6.2e-05	0.000121	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	6.16e-05	0.00012	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.81e-05	0.000113	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	5.79e-05	0.000113	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.63e-05	0.00011	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.42e-05	0.000106	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	5.36e-05	0.000104	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5.22e-05	0.000102	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.21e-05	0.000102	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	5.17e-05	0.000101	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.15e-05	0.0001	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	5.08e-05	9.89e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	5.01e-05	9.75e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—INS—polycystic ovary syndrome	4.98e-05	9.7e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	4.92e-05	9.59e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	4.91e-05	9.56e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.86e-05	9.47e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.78e-05	9.32e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	4.67e-05	9.09e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	4.38e-05	8.53e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.35e-05	8.48e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.17e-05	8.13e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.14e-05	8.06e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.03e-05	7.84e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.95e-05	7.7e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.79e-05	7.38e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	3.69e-05	7.18e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.53e-05	6.87e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.48e-05	6.78e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.46e-05	6.74e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.38e-05	6.58e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.22e-05	6.27e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.05e-05	5.94e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.99e-05	5.82e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.95e-05	5.74e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.93e-05	5.71e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.85e-05	5.54e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.31e-05	4.49e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.28e-05	4.43e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.26e-05	4.41e-05	CbGpPWpGaD
